AGXT and stroke disorder: To investigate any possible association between the de novo sphingolipid pathways and stroke, we assessed protein expression profiles of SPTLC1 and 2, two subunits of SPT, the rate-limiting enzymes in the de novo biosynthesis of sphingolipids [13], in both cerebral and renal tissues.